Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-Expressing platinum-resistant ovarian Cancer (PENELOPE)

1. Kurzeder, C.
2. Bover, I.
3. Marḿe, F.
4. Rau, J.
5. Pautier, P.
6. Colombo, N.
7. Lorusso, D.
8. Ottevanger, P.
9. Bjurberg, M.
10. Marth, C.
11. Barretina-Ginesta, P.
12. Vergote, I.
13. Floquet, A.
14. Campo, J.M.D.
15. Mahner, S.
16. Bastíere-Truchot, L.
17. Martin, N.
18. Oestergaard, M.Z.
19. Kiermaier, A.
20. Schade-Brittinger, C.
21. Polleis, S.
22. Bois, A.D.
23. Gonzalez-Martin, A.